Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Mild Cognitive Impairment (MCI) linked to Alzheimer's disease or Parkinson's disease, based on recognised international diagnostic guidelines
- People who have been diagnosed with Subjective Cognitive Decline (SCD), meaning they notice memory or thinking changes but standard tests do not show clear impairment, based on recognised research diagnostic criteria
- People who are between 40 and 80 years old and have completed at least 5 years of formal education
Who may not be able to join:
- People who have a diagnosed psychiatric condition, such as major depression, psychosis, or an anxiety disorder
- People who have severe dementia
- People who have a history of a stroke or reduced blood flow to the brain (cerebral ischemia)
- People who cannot safely have a brain MRI scan — this includes those who are pregnant, have a pacemaker, have older-model metal joint implants, have electrodes, neurostimulators, or any implants or devices that could be affected by strong magnetic fields, unless a written statement of MRI suitability has been provided by the specialist who carried out the original procedure (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rosso Salvatore Calabrò, MD,PhD, IRCCS Centro Neurolesi Bonino Pulejo
Phone: +39 090 62128250
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cognitive Performance Improvement; Social Cognition Enhancement
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.